Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cytokinetics (NQ: CYTK )

62.10 -1.92 (-3.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,343,714
Open 63.63
Bid (Size) 61.00 (1)
Ask (Size) 62.10 (1)
Prev. Close 64.02
Today's Range 61.25 - 64.61
52wk Range 25.98 - 110.25
Shares Outstanding 95,640,600
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q1 2024
CYTK stock results show that Cytokinetics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy. 
Via InvestorPlace

Performance

YTD
-26.18%
-26.18%
1 Month
-16.49%
-16.49%
3 Month
-19.29%
-19.29%
6 Month
+91.08%
+91.08%
1 Year
+64.16%
+64.16%

More News

Read More
(CYTK) - Analyzing Cytokinetics's Short Interest
Via Benzinga
3 Biotech Stocks to Buy on the Dip: April 2024
Via InvestorPlace
$100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
2 Incredible Growth Stocks to Buy Right Now
Via The Motley Fool
Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
Via Benzinga
Unpacking the Latest Options Trading Trends in Cytokinetics
Via Benzinga
Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
Via Benzinga
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
Via InvestorPlace
Masters In Trading - Saturday, March 16
Via Talk Markets
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
Via InvestorPlace
Super Micro, Deckers To Join S&P 500 Index
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 27, 2024
Via Benzinga
Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
Via Benzinga
Overbought, Overextended - What's The Buzz In S&P 500 Now?
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Biotech Stocks to Buy for the Next Bull Run: February 2024
Via InvestorPlace
How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
Via Investor's Business Daily
Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
Via InvestorPlace
Biotech Playbook: Small Caps Show Momentum Peaking During
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
Via Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.